These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 2047070)

  • 41. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prognostic value of intraoperative pleural lavage cytology for lung cancer without carcinomatous pleuritis: importance in patients with early stage disease during long-term follow-up.
    Higashiyama M; Oda K; Okami J; Maeda J; Kodama K; Takenaka A; Nakayama T; Yoneda G
    Eur J Cardiothorac Surg; 2009 Feb; 35(2):337-42. PubMed ID: 19041255
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Histopathologic score predicts recurrence free survival after radical surgery in patients with stage IA2-IB1-2 cervical carcinoma.
    Grisaru DA; Covens A; Franssen E; Chapman W; Shaw P; Colgan T; Murphy J; DePetrillo D; Lickrish G; Laframboise S; Rosen B
    Cancer; 2003 Apr; 97(8):1904-8. PubMed ID: 12673716
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Parotid metastasis--an independent prognostic factor for head and neck cutaneous squamous cell carcinoma.
    Ch'ng S; Maitra A; Lea R; Brasch H; Tan ST
    J Plast Reconstr Aesthet Surg; 2006; 59(12):1288-93. PubMed ID: 17113505
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical characteristics of prognostic factors in uterine endometrioid adenocarcinoma of various grade.
    Dvalishvili I; Charkviani L; Turashvili G; Burkadze G
    Georgian Med News; 2006 Mar; (132):24-7. PubMed ID: 16636372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the endometrium.
    Carey MS; O'Connell GJ; Johanson CR; Goodyear MD; Murphy KJ; Daya DM; Schepansky A; Peloquin A; Lumsden BJ
    Gynecol Oncol; 1995 May; 57(2):138-44. PubMed ID: 7729725
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems.
    Le QT; Fu KK; Kaplan M; Terris DJ; Fee WE; Goffinet DR
    Cancer; 1999 Nov; 86(9):1700-11. PubMed ID: 10547542
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Recurrence of endometrial cancer and its pathological factors].
    Kondo Y; Gorai I; Yanagibashi T; Yanagisawa T; Hirahara F; Ohtsuka T; Kimura A; Uemura T; Minaguchi H; Kikyo S
    Nihon Gan Chiryo Gakkai Shi; 1990 Jun; 25(6):1105-9. PubMed ID: 2398296
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Predictors of recurrence and prognosis in patients with stage I and II endometrial carcinoma].
    Li M; Wang Z; Zhao L; Li X; Wang J; Zhang C; Wei L
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jun; 49(6):455-9. PubMed ID: 25169640
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Comparison between old and new FIGO staging of endometrial carcinoma--the significance of positive peritoneal cytology].
    Yokosuka K; Katase K; Umezawa S; Hirai Y; Hasumi K
    Nihon Sanka Fujinka Gakkai Zasshi; 1994 Dec; 46(12):1359-65. PubMed ID: 7852775
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of adenocarcinoma of the endometrium at Memorial-James Ewing Hospitals, 1949-1965.
    Homesley HD; Boronow RC; Lewis JL
    Obstet Gynecol; 1976 Jan; 47(1):100-5. PubMed ID: 1246374
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosarcoma of the uterus: a Gynecologic Oncology Group clinicopathologic study of 31 cases.
    Kaku T; Silverberg SG; Major FJ; Miller A; Fetter B; Brady MF
    Int J Gynecol Pathol; 1992; 11(2):75-88. PubMed ID: 1316323
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Risk factor analysis of recurrence in low-grade endometrial adenocarcinoma.
    Roma AA; Rybicki LA; Barbuto D; Euscher E; Djordjevic B; Frauenhoffer E; Kim I; Hong SR; Montiel D; Ali-Fehmi R; Malpica A; Silva EG
    Hum Pathol; 2015 Oct; 46(10):1529-39. PubMed ID: 26264257
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlation of tumor size with other prognostic factors in uterine serous carcinoma: a large multi-institutional study.
    Winer I; Mahdi H; Bandyopadhyay S; Semaan A; Van de Vijver KK; Nucci MR; Abdul-Karim F; Hussein Y; Qureshi F; Hayek K; Alosh B; Schulz D; Cote M; Munkarah A; Morris R; Oliva E; Ali-Fehmi R
    Gynecol Oncol; 2013 Feb; 128(2):316-21. PubMed ID: 23138135
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical stage I endometrial cancer: prognostic factors for local control and distant metastasis and implications of the new FIGO surgical staging system.
    Grigsby PW; Perez CA; Kuten A; Simpson JR; Garcia DM; Camel HM; Kao MS; Galakatos AE
    Int J Radiat Oncol Biol Phys; 1992; 22(5):905-11. PubMed ID: 1555983
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Recurrent adenocarcinoma of the uterus].
    Tuskan E; Lovrić B; Navratil I; Tuskan N
    Jugosl Ginekol Perinatol; 1991; 31(1-2):40-2. PubMed ID: 1875722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Multivariate statistical analysis of the postoperative recurrence factors in uterine cervical carcinoma].
    Ito T; Yago H; Kuribayashi M; Osawa H
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Mar; 40(3):338-44. PubMed ID: 3361186
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Results of assays of estrogen, progesterone and androgen receptors in stage I and II adenocarcinoma of the endometrium].
    Cormier P; Floquet A; Wafflart J; Coindre JM; Bonichon F; Marée D
    Rev Fr Gynecol Obstet; 1991; 86(7-9):491-4. PubMed ID: 1754802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.